Sequence with the Leaders

In Cannabis, Mushroom, and Microbial Genomics

Medicinal Genomics uses its unmatched knowledge of the cannabis genome, P. cubensis genome, and the microbes that impact both organisms to create a variety of genomic services that provide valuable insights and actionable data.

Applications

Cannabis and Hemp Sequencing

Genotype plants, identify novel variants, and protect IP using the most advanced genomic tools on the market.

Mushroom Sequencing

Map all 40+ million bases of the P. cubensis genome to the most complete and comprehensive reference genome, delivered on Psilocydia.net.

Microbial Speciation

Identify which microbial species triggered a Total Yeast and Mold, Total Aerobic Count, or Bile Tolerant Gram Negative failure.

What our customers are saying

Matt Wheatley, PhD | Director of Cultivation, Los Suenos Farms
“I am very happy with the StrainSEEK® results I received from Medicinal Genomics. Being a molecular biologist, I plan to spend a great deal of time perusing the StrainSEEK® sequence info up close to begin to understand the differences we see in growth and disease resistance for different varieties. For example, a few of the varieties we grow have a great deal more resistance to fungal pathogens when compared with the average variety. Identification of genetic markers that impart disease resistance is incredibly important to future breeding projects. Medicinal Genomics has given me a goldmine 🙂 thanks again!”
Seth Crawford, PhD | Co-founder, Oregon CBD
“The CannSNP90 Platform is a very powerful tool for cannabis breeders. and can rapidly accelerate the process of marker discovery. In our case, it has helped us take our breeding of high total cannabinoid content in novel chemotype hemp to the next level and made it possible to identify day-neutral plants as seedlings, which are both equally groundbreaking results for us. We will definitely be using this service again.”
Previous slide
Next slide

Trusted By

Relevant Publications

The Medicinal Genomics team has published extensively on the topics related to sequencing cannabis, hemp, mushrooms, and the microbes that affect them.

A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. K McKernan, L Kane, Y Helbert, L Zhang, N Houde, S McLaughlin F1000Research 10 (961), 961 Read More >
A draft reference assembly of the Psilocybe cubensis genome K McKernan, LT Kane, S Crawford, CS Chin, A Trippe, S McLaughlin F1000Research 10 Read More >
Single molecule sequencing of THCA synthase reveals copy number variation in modern drug-type Cannabis sativa L

KJ McKernan, Y Helbert, V Tadigotla, S McLaughlin, J Spangler, L Zhang, …BioRxiv, 028654

Read More >

Related Resources

Oregon CBD Accelerates Breeding With Genomics

Using Genomic Services the OregonCBD team was able to:
  • Identify specific genomic markers associated with desirable traits such as autoflower
  • Create a qPCR assay that can determine whether a seedling has the autoflower marker
  • Accelerate their breeding program by enabling earlier selections and using space more effectively 
  •  

Genomic Tools for Cannabis Sativa and Psilocybe Cubensis Propagation

MGC CSO Kevin McKeran describes how his team constructed a chromosome-scale, annotated reference genome for Psilocybe cubensis and used it sequence and map an additional 81 Psilocybe genomes. He also debuta a new open source, blockchain-integrated genome browser called Psilocydia.

Have questions? Our experts are here for you

Our genetics-based cannabis testing and breeding technologies can help growers, dispensaries and labs grow cleaner, faster and healthier in every way. Because you’re not just delivering a product. You’re building a business. And a reputation.

Fill form to watch Video